Why the study?
Progestin-only pills avoid thrombotic risks but cause poor cycle control, prompting evaluation of whether a novel drospirenone-only pill improves bleeding profiles and reduces bleeding-related discontinuations compared to desogestrel.
Does drospirenone 4 mg reduce discontinuation rates compared to desogestrel 0.075 mg in healthy women aged 18-45 years?
Population
Healthy women aged 18-45 years (858 receiving DRSP and 332 receiving DSG)
Comparison
Drospirenone (DRSP) vs desogestrel (DSG)
Design
Double-blind, double-dummy prospective phase III study
Authors
Loading...
DRSP-only pill may improve adherence via better bleeding control; extends RCT evidence favoring it over other progestin-only options.
Does drospirenone 4 mg reduce discontinuation rates compared to desogestrel 0.075 mg in healthy women aged 18-45 years?
A drospirenone-only oral contraceptive significantly reduces discontinuation rates due to abnormal bleeding compared to desogestrel.
Regidor et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: